Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2022 ∙ Müller, K. E. Dohos, D. Sipos, Z. Kiss, S. Dembrovszky, F. Kovács, N. Solymár, M. Erőss, B. Hegyi, P. Sarlós, P.

Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: A systematic review and meta-analysis of 1429 patients

  • Adults
  • Older adults
  • Pneumococcal disease
  • Influenza
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Guzman-Holst, A. de Barros, E. Rubio, P. DeAntonio, R. Cintra, O. Abreu, A.

Impact after 10-year use of pneumococcal conjugate vaccine in the Brazilian national immunization program: an updated systematic literature review from 2015 to 2020

  • Americas
  • Brazil
  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Britt, A. F. Poupore, N. S. Nguyen, S. A. White, D. R.

Improving Pneumococcal Vaccination Rates in Cochlear Implant Programs: A Systematic Review and Meta-analysis

  • All age groups
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Kapoula, G. V. Vennou, K. E. Bagos, P. G.

Influenza and Pneumococcal Vaccination and the Risk of COVID-19: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Influenza
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Fudman, D. I. Perez-Reyes, A. E. Niccum, B. A. Melmed, G. Y. Khalili, H.

Interventions to Decrease Unplanned Healthcare Utilization and Improve Quality of Care in Adults With Inflammatory Bowel Disease: A Systematic Review

  • Adults
  • Older adults
  • Pneumococcal disease
  • Influenza
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Wang, Z. Chen, S. Fang, Y.

Parental Willingness and Associated Factors of Pediatric Vaccination in the Era of COVID-19 Pandemic: A Systematic Review and Meta-Analysis

  • All age groups
  • Parents/caregivers
  • Pneumococcal disease
  • Human papillomavirus (HPV)
  • Influenza
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Tvedskov, E. S. F. Hovmand, N. Benfield, T. Tinggaard, M.

Pneumococcal carriage among children in low and lower-middle-income countries: A systematic review

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Shao, W. Chen, X. Zheng, C. Wang, G. Zhang, B. Zhang, W.

Pneumococcal vaccination coverage and willingness in mainland China

  • Western Pacific
  • China
  • All age groups
  • Healthcare workers
  • Pneumococcal disease
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Syeed, M. S. Ghule, P. Le, L. M. Veettil, S. K. Horn, E. K. Perdrizet, J. Wasserman, M. Thakkinstian, A. Chaiyakunapruk, N.

Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies

  • Children
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Bencina, G. Fues Wahl, H. Tsoumani, E. Salomonsson, S.

Recommendations and Health Technology Assessment (HTA) landscape evaluation for pediatric pneumococcal conjugate vaccines (PCV) in Europe: a systematic literature review

  • Europe
  • Children
  • Pneumococcal disease
  • Economic aspects
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
Loading...